Keywords: IUGR; intrauterine growth restriction; HPA axis; hypothalamic pituitary adrenal axis; HPO axis; hypothalamic pituitary ovarian axis; LC/NE; locus ceruleus/norepinephrine; CRH; corticotropin releasing hormone; AVP; arginine vasopressin; PVN; paraventricula
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: PCOS; Selenium; Zinc; Insulin resistance;
Keywords: HCG; human chorionic gonadotropin; E2; serum estradiol; P; progesterone; T; testosterone; LH; luteinizing hormone; FSH; follicle-stimulating hormone; ELISA; enzyme-linked immunosorbent assay; ERβ; estrogen receptor beta; IVF; in vitro fertilization; PCOS
Keywords: Probiotics; Lactobacillus; Polycystic ovary syndrome; PCOS; Interleukins; hs-CRP;
Keywords: PCOS; BMI; Hypertensive disorders of pregnancy; Obesity; Preeclampsia; RHINE;
Keywords: PCOS; polycystic ovary syndrome; BMI; mody mass index; HDL-C; high density lipoprotein-C; LDL-C; low density lipoprotein-C; CVD; cardiovascular disease; FSH; follicle stimulating hormone; LH; luteinizing hormone; T2DM; type 2 diabetes mellitus; GPO-PAP; g
Keywords: PCOS; polycystic ovary syndrome; NK; natural killer; uNK; uterine natural killer; KIRs; killer-cell immunoglobulin-like receptors; iKIR; Kir inhibitors; ITIM; tyrosine-based inhibitory motifs; aKIR; Kir activators; ITAM; tyrosine-based activation motifs;
Keywords: Bone morphogenetic protein (BMP); Granulosa cells; Metformin; Smad and steroidogenesis; ActRII; activin type-II receptor; ALK; activin receptor-like kinase; AMPK; AMP-activated protein kinase; BMP; bone morphogenetic protein; BMPRII; BMP type-II receptor;
Keywords: Adolescence; Hyperandrogenemia; Hyperinsulinism; Insulin resistance; PCOS; PSA;
Keywords: Polycystic ovary syndrome; PCOS; IVF; PFAA; Endocrine disrupting chemicals; Perfluorinated alkyl acids; PFOS; PFOA; PFHxS; PFNA;
Keywords: Hirsutism; PCOS; Androgens; HPA-axis; Stressor event;
Keywords: PCOS; weight loss; depression; CBT; nutrition;
Keywords: Mass-spectrometry; Proteomics; Endocrinology; Children; Pediatrics; 17OHPG; 17-Hydroxyprogesterone; Apo; Apolipoprotein; CAH; Congenital Adrenal Hyperplasia; CDG; Congenital Disorders of Glycosylation; DHEAS; Dehydroepiandrosterone Sulfate; DN; Diabetic N
Keywords: Endometrium; Luteal phase; PCOS; Polycystic ovary syndrome; Proliferative phase; Proteomics;
Keywords: Testosterone; Immunoassay; Radioimmunoassay; Chemiluminescence; Liquid chromatography-tandem mass spectrometry; CI; confidence interval; CLIA; chemiluminescence immunoassay; CV; coefficient of variation; FIB; Fertility and Infertility Branch; LAAC-CRR; Li
Keywords: Hyperandrogenism; Metabolic syndrome; Obesity; PCOS; Rotterdam phenotypes;
Keywords: AgRP; Agouti-related protein; ARC; Arcuate nucleus; BMI; Body mass index; Clâ; Chloride ion; CNS; Central nervous system; GABA; γ-aminobutyric acid; GABAA-receptor; γ-aminobutyric acid receptor type A; GAMS; GABAA-receptor modulating steroids; GAMSA;
Keywords: AC; adenylate cyclase; ALK; activin receptor-like kinase; ActRII; activin type-II receptor; BMP; bone morphogenetic protein; BMPRII; BMP type-II receptor; FSH; follicle-stimulating hormone; FSHR; FSH receptor; GDF; growth and differentiation factor; GIP;
Keywords: PCOS; polycystic ovary syndrome; DEGs; differentially expressed genes; PPI; protein-protein interaction; POLR1B; polymerase I subunit B; POLE3; polymerase epsilon 3, accessory subunit; POLD3; polymerase delta 3, accessory subunit; HTR2C; 5âhydroxytrypta
Keywords: POMC; pro-opiomelanocortin; NPY; neuropeptide Y; AgRP; agouti-related peptide; PCOS; polycystic ovary syndrome; BAT; brown adipose tissue; WAT; white adipose tissue; Myf5; myogenic factor 5; PRDM16; PRD1-BF1-RIZ1 homologous domain containing 16; UCP1; the
Keywords: Androgens; Androgen receptor; Ovary; PCOS;
Keywords: ABCA1; ATP-binding cassette transporter; ACOG; American College of Obstetricians and Gynecologists; ACSM; American College of Exercise Medicine; AMPK; AMP-activate protein kinase; ADA; American Diabetes Association; BMI; body mass index; BMR; Basal metabo
Keywords: Androgens; Intracrinology; Steroid biosynthesis; Hormone-dependent cancer; Testosterone; 11-oxygenated androgens; 11KA4; 11-keto-androstenedione; 11KDHT; 11-keto-5α-dihydrotestosterone; 11KT; 11-keto-testosterone; 11OHA4; 11β-hydroxy-androstenedione; 11
Keywords: PCOS; polycystic ovary syndrome; ESHRE/ASRM; European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine; IH; idiopathic hirsutism; IHA; idiopathic hyperandrogenemia; HAA; hyperandrogenemia associated acne; HOMA-IR; h
Keywords: QSM; Quantitative susceptibility mapping; GRE; gradient echo; PDF; Projection onto Dipole Fields; MEDI; morphology enabled dipole inversion; ROI; region of interest; PSF; point spread function; FWHM; full-width-half-maximum; PCOS; projection onto convex s
Keywords: Endometrial cancer; insulin-sensitizing agents; metformin; secretagogues; population-based; AMPK; activated protein kinase; ISA; insulin-sensitizing agent; PC; principal component; PCA; principal components analysis; PCOS; polycystic ovary syndrome; TZD;
Keywords: Hirsutism; polycystic ovary syndrome; libido; androgen assays; 11KDHT; 11-ketodihydrotestosterone; DHEAS; dehydroepiandrosterone; DHT; dihydrotestosterone; PCOS; polycystic ovary syndrome; SSE; satisfying sexual episode;
Keywords: Diabetes; incidence; PCOS; prediabetes; population-based cohort study;
Keywords: Anthropometry; Body composition; Body mass index; Infertility; PCOS;
Keywords: PCOS; hirsutism; ethnicity; Fitzpatrick skin type; hyperandrogenism; modified Ferriman-Gallwey;
Keywords: Follicular fluid; Oocyte; Cytokine; PCOS; Metabolic syndrome;
Keywords: PCOS; Hepatic fat; Visceral fat; Ovulation; Spironolactone; Pioglitazone; Metformin;
Keywords: cannabinoid receptors; CB1; endocannabinoids; fatty acid amide hydrolase; FAAH; polycystic ovary syndrome; PCOS; metformin;
Keywords: Hyperandrogenic; PCOS; pregnancy complications;
Keywords: PCOS; diagnosis; treatment; physician survey; gaps in knowledge;
Keywords: PCOS; Systematic review; Meta-analysis; Drospirenone;
Keywords: Polycystic ovary syndrome; Obesity; Binge eating; Food cravings; Eating disorders; PCOS; Polycystic ovary syndrome;
Keywords: AMH; PCOS; Dietary pattern; Hyperandrogenism; Phenotype; Ongoing pregnancy;
Keywords: IVM; in vitro maturation; IVF; in vitro fertilization; ART; assisted reproductive technologies; OHSS; ovarian hyperstimulation syndrome; PCOS; polycystic ovary symdromes; ICSI; intracytoplasmic sperm injection; MDI; Mental Development Index; VVM; in vivo
Keywords: AD; Alzheimer'”s disease; Aβ; beta amyloid; ApoE4; apolipoprotein E4 genotype; T2DM; type 2 diabetes mellitus; GSK3β; glucose synthase kinase 3 beta; Drp1; dynamin-related protein1; ROS; reactive oxygen species; WHO; World Health Organization; ADA; Am
Keywords: Density equalizing mapping; Diagnosis; Female health; PCOS; Prevention; Socioeconomic analysis;
Keywords: fibroids; Mullerian aplasia; POF; OHSS; hypogonadism; Kallmann syndrome; PCOS; endometriosis;
Keywords: competence; fertility; infertility; oocyte; PCOS; quality;
Keywords: Metformin; Hyperandrogenism; Insulin resistance; Molecular mechanism; PCOS; Rat uterus;
Keywords: PCOS; polycystic ovarian syndrome; ED; endothelial dysfunction; MS; metabolic syndrome; CVRF; cardiovascular risk factors; OS; oxidative stress; CMC; cardiometabolic syndrome; CVD; cardiovascular disease; T2D; diabetes mellitus; IR; insulin resistance; CV
Keywords: AMPK; AMP-activated protein kinase; Arg; arginine; Asp; aspartate; Cit; citrulline; ESI-LC-MS/MS; electrospray ionization liquid chromatography-mass spectrometry; Orn; ornithine; OTC; ornithine transcarbamoylase; PC; phosphatidylcholine; PC aa; diacyl-p
Keywords: Immunomodulators; Drug; Side Effect; Risk; Neonate; Infant; 6-MMP; 6-methylmercaptopurine; 6-TGN; 6-thioguanine nucleotides; aOR; adjusted odds ratio; AZA; azathioprine; BMI; body mass index; CD; Crohn's disease; CI; confidence interval; cOR; crude odds
Keywords: α-Aminoadipic acid; Branched-chain amino acids; Insulin sensitivity; Metabolic syndrome; Vitamin D; 1,25(OH)2D2; 1,25-dihydroxyvitamin D2; 1,25(OH)2D3; 1,25-dihydroxyvitamin D3; 25(OH)D2; 25-hydroxyvitamin D2; 25(OH)D3; 25-hydroxyvitamin D3; α-AA; α-am
Keywords: Macrophage; Adipose; Inflammation; Obesity; Fibrosis; Insulin; AMPK; AMP-activated protein kinase; ATM; adipose tissue macrophages; CRP; C-reactive protein; DIO; diet-induced obesity; DPP-4; dipeptidyl peptidase-4; FFA; free fatty acids; GLP-1; glucagon-l